MANALIPETC and CHEMFAB, both in Chemicals: Major. Monthly data through 2026-10-09. Change the comparison →
Share price change since Jan '19, the first month all 2 have a price: MANALIPETC +241%, CHEMFAB +118%.
Rebased at 2019-01. Monthly closes from each company's history.
Months with a missing value are left as gaps.
The share price return over 3 years, split into net profit growth, share count change and the change in P/E.
MANALIPETC: share price rose 26% over 3 years: +61 pts from net profit growth, −35 pts from the P/E change.
CHEMFAB: share price fell 6% over 3 years: −219 pts from net profit growth, +214 pts from the P/E change, −1 pts from share count change.
Segments are percentage points of the price return: price = P/E × net profit ÷ share count. These are the same numbers each company's own page shows.
Each cell is the company's percentile rank among its own sector peers that month. Darker is higher-ranked. Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value.
| Metric | MANALIPETC | CHEMFAB |
|---|---|---|
| Share Price | ₹85.87 | ₹332.30 |
| Market Cap | ₹1490 cr | ₹476 cr |
| P/E | 16.9x | 68.7x |
| P/B | 1.5x | 1.2x |
| P/S | 1.7x | 1.7x |
| ROCE | 3.0% | 3.0% |
| ROE | 9.0% | 1.7% |
| Operating margin | 32.0% | 11.7% |
| Revenue (TTM), indexed to 100 | ₹852 cr | ₹274 cr |
| Net Profit (TTM) | ₹88 cr | ₹7 cr |
| Debt / Equity | 0.1x | 0.3x |
| Cash Conversion Cycle | 85d | -1d |
| Promoter holding | 44.9% | 72.1% |
| FII Holding | 0.4% | 0.0% |
| DII Holding | 0.0% | 0.1% |
| 12M momentum | 16.1% | -45.4% |
| Drawdown from Peak | -34.8% | -69.3% |
| Cash conversion (3Y) | 1.2x | 2.9x |
| Interest cover | 10.3x | 1.5x |
| Share Count Change (1Y) | 0.0% | 0.0% |
| Volatility (1Y) | 47.1% | 40.9% |
Latest month in the data: 2026-10. Highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment.
Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment. Not investment advice; ApnaFunda is not a SEBI-registered research analyst.